Researchers at Columbia University discovered that a specialized proteasome system on the surface of neurons — called the neuroproteasome — plays a central role in preventing the toxic tau tangles seen in Alzheimer's disease. When this system is disrupted, neurons rapidly form tau paired helical filaments nearly identical to those found in human Alzheimer's brains. Crucially, the APOE gene — the strongest known genetic risk factor for Alzheimer's — directly regulates how much neuroproteasome activity neurons maintain. People with the APOE4 variant have less of this protective system and are far more vulnerable to tau aggregation, while APOE2 carriers appear more resilient. This neuroproteasome activity also declines naturally with aging, helping explain why age and genetics together drive Alzheimer's risk. The findings open a new therapeutic avenue: boosting neuroproteasome function may protect against tau pathology.
